WASTE MANAGEMENT INC (WM)
WM Sets Date for Second Quarter 2026 Earnings Conference Call
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND (AFB)
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS SECOND QUARTER EARNINGS
Monopar Therapeutics Inc. (MNPR)
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
UNIVERSE PHARMACEUTICALS INC (UPC)
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
LARIMAR THERAPEUTICS, INC. (LRMR)
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
MONOPAR THERAPEUTICS (MNPR)
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
FASTENAL CO (FAST)
Fastenal Company Announces Conference Call to Review 2026 Second Quarter Earnings
INVENTRUST PROPERTIES CORP. (IVT)
InvenTrust Properties Corp. Announces Second Quarter 2026 Earnings Release and Conference Call Dates
ASCENDIS PHARMA A/S (ASND)
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
LANTHEUS HOLDINGS, INC. (LNTH)
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)